Jacobs Jeffrey W 4
4 · ARDELYX, INC. · Filed Jun 17, 2021
Insider Transaction Report
Form 4
ARDELYX, INC.ARDX
Jacobs Jeffrey W
VP, Chemistry
Transactions
- Exercise/Conversion
Common Stock
2021-06-15$0.54/sh+7,500$4,050→ 131,551 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-06-15−7,500→ 10,000 totalExercise: $0.54Exp: 2021-08-11→ Common Stock (7,500 underlying) - Sale
Common Stock
2021-06-15$7.29/sh−7,500$54,659→ 124,051 total
Footnotes (3)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 10, 2021.
- [F2]This transaction was executed in multiple trades in prices ranging from $7.242 to $7.41, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]The option, which was granted on August 11, 2011 and has an expiration date of August 11, 2021, is fully vested and exercisable.